UBS’s PROLOR Biotech, Inc. Common Stock PBTH Stock Holding History

UBS’s Portfolio PBTH Stock Details PBTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-65,800	Closed	-$414K	–	11197
2013 Q2	$414K	Buy	+65,800	New	+$394K	﹤0.01%	4286

Other funds holding PBTH

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

UBS's PBTH Position: Q3 2013 in Review

UBS sold out of PROLOR Biotech, Inc. Common Stock (PBTH) in Q3 2013, closing a stake of 172,099 shares — an estimated $1.08M sold.

UBS first reported a position in PBTH in Q2 2013 and held it in 1 quarter. The position peaked at $1.08M in Q2 2013. 3 funds tracked by Wall St. Rank hold PBTH as of Q3 2013.

UBS reported no remaining PROLOR Biotech, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
UBS sold 172,099 PROLOR Biotech, Inc. Common Stock shares in Q3 2013, an estimated $1.08M.
UBS first reported a position in PROLOR Biotech, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
UBS's PROLOR Biotech, Inc. Common Stock position peaked at $1.08M in Q2 2013.
3 funds tracked by Wall St. Rank held PROLOR Biotech, Inc. Common Stock as of Q3 2013.

Based on UBS's 13F filing for Q3 2013, filed 13 Nov 2013.